Axelrod said that Medicare for All has “become a phrase as much as anything else.”
Even if investors are still unsure how the Bristol-Myers Squibb (BMS) and Celgene merger might pan out, one thing is certain:  executives will get bigger salaries and the resulting Big Pharma company will likely get a surge of power. With investors’ initial hesitance pushed aside, Bristol-Myers Squibb investors approved...
The Senate Special Committee on Aging has just released one of the most damning reports on the nation’s nursing homes that I’ve seen in a long time. The short document should be required reading for any family thinking of moving a relative to a nursing facility. Pennsylvania Senator Robert Casey,...
The new class of Democratic representatives entered Congress on an independent streak, disavowing corporate PACs and championing grassroots support. Many kept to their words, but major health corporations and associated donors still made their influence apparent. In fact, every Democratic Freshman representative took some form of money from health...
If ever there were a weak link in hospital care, it's what happens when you or a loved one leaves the hospital. It's becoming clear that the process known as discharge planning is deficient, can be harmful, and sometimes results in a patient's decline. One in five patients across the...
An Appalachian physician explains how just five insurance powers control most of the market and what that means for patients.
The health industry is gearing up to be a major influence in 2020, and making it known from the first round of campaign contributions. Tarbell reviewed the top 20 health industry contributors in the 2017-2018 election cycle, according to OpenSecrets, to see how much they’ve shelled out in the...
“There are millions of people in this country who can’t afford to go to the dentist. Millions.”
Oral Health in America:Removing the Stain of Disparity details inequities to an oral health care system that disproportionately affects the poor, those without insurance, underrepresented and underserved communities, the disabled, and senior citizens. This book addresses issues in workforce development including the use of dental therapists, the rationale for the...
This New York City subway ad recently caught my attention: “When researching hospitals, consider how much research they do.” The ad for Mt. Sinai Health System advised riders that the research “we do today drives medicine we will do tomorrow,” and the hospital system was proud that it ranked...
An Appalachian physician explains how health care system mergers result in staff layoffs and have negative effects on his community’s economy.
Rochester Drug Cooperative (RDC) is the first company to be charged for knowingly pumping fentanyl, oxycodone and other opioids into America’s most drug overdosed cities and towns. In the wake of that lawsuit, Tarbell found RDC has been deeply tied to a lobbying organization that presents itself as an...
Health care industry propagandists proceed cautiously at first-ever hearing on Medicare For All bill.
Propagandists are trying to force Congress and voters to make fear-based choices about health care.
If ever there were an award for the best “buyer beware” story, a tale detailing the pitfalls of short-term health insurance would certainly rise to the top of the list of nominees. Short-term policies — not to be confused with association policies I’ve written about before — are hitting the...
Former Iowa governor Terry Branstad, who instituted the privatization with a claim of saving money, was a founding member of the influential, Koch-brother affiliated American Legislative Exchange Council and now his legacy causes chaos for patients, doctors and hospitals in the state.
The tribulations of fighting unfair denials from PBMs and how one patient taped her calls. Listen to her calls within.
Recently Peggy, an Indiana woman and reader of this column, sent me a lengthy email about her 94-year-old mother who is rapidly spending down her minimal savings to pay for prescription drugs.   Peggy didn’t hold out much hope that prices would come down before it was too late for...
High drug prices are Americans’ number one health care concern. The average price of a cancer drug rose from less than $10,000 a year before 2000 to more than $170,000 a year in 2017. Between 1995 and 2013, the launch price of cancer drugs increased by 10 to 12...
This analysis was written by Tarbell board member Diane Archer and originally published in the health news and advisory platform Just Care on 3/6/2019. Tarbell is republishing this piece with permission.